Smithbridge Asset Management Inc Abb Vie Inc. Transaction History

Smithbridge Asset Management Inc

$483 Million
Q1 2024

A detailed history of Smithbridge Asset Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Smithbridge Asset Management Inc holds 47,086 shares of ABBV stock, worth $7.59 Million. This represents 1.78% of its overall portfolio holdings.

Number of Shares

47,086

Previous 48,469 2.85%

Holding current value

$7.59 Million

Previous $7.51 Million 14.15%

% of portfolio

1.78%

Previous 1.71%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $221,031 - $251,844	-1,383 Reduced 2.85%	47,086 $8.57 Million
Q4 2023 Jan 18, 2024	SELL	$137.6 - $154.97 $86,000 - $96,856	-625 Reduced 1.27%	48,469 $7.51 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $88,837 - $102,842	-665 Reduced 1.34%	49,094 $7.32 Million
Q2 2023 Jul 20, 2023	SELL	$132.51 - $164.9 $24,514 - $30,506	-185 Reduced 0.37%	49,759 $6.7 Million
Q2 2023 Jul 18, 2023	BUY	$132.51 - $164.9 $34,850 - $43,368	263 Added 0.53%	49,944 $8.07 Million

Q1 2023 Apr 20, 2023	SELL	$144.61 - $166.54 $38,032 - $43,800	-263 Reduced 0.53%	49,681 $7.92 Million
Q4 2022 Mar 01, 2023	BUY	$138.31 - $165.87 $3.2 Million - $3.84 Million	23,134 Added 86.29%	49,944 $8.07 Million
Q3 2022 Oct 25, 2022	SELL	$134.21 - $153.93 $80,257 - $92,050	-598 Reduced 2.18%	26,810 $3.6 Million
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $68,121 - $86,605	495 Added 1.84%	27,408 $4.2 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $14,253 - $17,685	-108 Reduced 0.4%	26,913 $4.36 Million
Q4 2021 Jan 24, 2022	BUY	$107.43 - $135.93 $2.9 Million - $3.67 Million	27,021 New	27,021 $3.66 Million
Q3 2021 Oct 04, 2021	BUY	$106.4 - $120.78 $27,344 - $31,040	257 Added 0.95%	27,178 $2.93 Million
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $49,133 - $54,737	467 Added 1.77%	26,921 $3.03 Million
Q4 2020 Jan 21, 2021	SELL	$80.49 - $108.67 $22,456 - $30,318	-279 Reduced 1.04%	26,454 $2.84 Million
Q2 2020 Jul 01, 2020	SELL	$73.37 - $98.18 $22,011 - $29,454	-300 Reduced 1.11%	26,733 $2.63 Million
Q1 2020 Apr 13, 2020	SELL	$64.5 - $97.79 $103,200 - $156,464	-1,600 Reduced 5.59%	27,033 $2.06 Million
Q4 2019 Jan 09, 2020	SELL	$72.13 - $90.25 $2.04 Million - $2.55 Million	-28,283 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$62.98 - $75.72 $31,490 - $37,860	-500 Reduced 1.74%	28,283 $2.14 Million
Q4 2018 Jan 15, 2019	BUY	$77.85 - $96.01 $24,289 - $29,955	312 Added 1.1%	28,783 $2.65 Million
Q3 2018 Oct 05, 2018	SELL	$88.91 - $98.84 $35,119 - $39,041	-395 Reduced 1.37%	28,471 $2.69 Million
Q2 2018 Jul 18, 2018	SELL	$89.78 - $106.23 $128,205 - $151,696	-1,428 Reduced 4.71%	28,866 $2.67 Million
Q1 2018 Apr 09, 2018	BUY	$92.01 - $123.21 $50,237 - $67,272	546 Added 1.84%	30,294 $2.87 Million
Q4 2017 Jan 18, 2018	BUY	$89.56 - $98.21 $20,330 - $22,293	227 Added 0.77%	29,748 $2.88 Million
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $2.06 Million - $2.63 Million	29,521	29,521 $2.62 Million

Others Institutions Holding ABBV

# of Institutions

3,643

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $285B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithbridge Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Smithbridge Asset Management Inc with notifications on news.

Account

Smithbridge Asset Management Inc Abb Vie Inc. Transaction History